Search research articles
Contact Us
Filters
Showing results (1-10 of 140) with videos related to
Page
of 14
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1991
Prostate cancer: should potency be preserved by deferring hormonal treatment in patients with asymptomatic metastatic disease?
M R Robinson
British Journal of Urology
|
August 1, 1980
Aminoglutethimide: medical adrenalectomy in the management of carcinoma of the prostate. A review after 6 years
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1990
Reasons against total androgen suppression
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1985
BCG in the management of superficial bladder cancer
M R Robinson
Cancer
|
December 15, 1993
A further analysis of European Organization for Research and Treatment of Cancer protocol 30805. Orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose diethylstilbestrol
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1987
Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1990
The management of end-stage carcinoma of the prostate: philosophy and fact
M R Robinson
American Journal of Clinical Oncology
|
January 1, 1988
Carcinoma of the prostate. Objective criteria of response
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1988
Is there a best endocrine management of prostatic carcinoma?
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1988
EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate
M R Robinson
Page
of 14
Search research articles
Search
Showing results (1-10 of 140) with videos related to
Sort By:
Page
of 14
Progress in Clinical and Biological Research
|
January 1, 1991
Prostate cancer: should potency be preserved by deferring hormonal treatment in patients with asymptomatic metastatic disease?
M R Robinson
British Journal of Urology
|
August 1, 1980
Aminoglutethimide: medical adrenalectomy in the management of carcinoma of the prostate. A review after 6 years
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1990
Reasons against total androgen suppression
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1985
BCG in the management of superficial bladder cancer
M R Robinson
Cancer
|
December 15, 1993
A further analysis of European Organization for Research and Treatment of Cancer protocol 30805. Orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose diethylstilbestrol
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1987
Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1990
The management of end-stage carcinoma of the prostate: philosophy and fact
M R Robinson
American Journal of Clinical Oncology
|
January 1, 1988
Carcinoma of the prostate. Objective criteria of response
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1988
Is there a best endocrine management of prostatic carcinoma?
M R Robinson
Progress in Clinical and Biological Research
|
January 1, 1988
EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate
M R Robinson
Page
of 14